Invox Pharma Limited

Mateusz Wydro

Francisca Wollerton

Matthew Lakins

Sachin Badrinath Surade

Michael Dyson

The present disclosure, in some aspects, provides antibody molecules, or antigen-binding fragments thereof capable of binding specifically to PD-L1. The present disclosure further provides antibody molecules, or antigen-binding fragments thereof capable of binding specifically to PD-L1 and a second antigen-binding site. Methods of making and/or using such antibody molecules or antigen bending fragments are also provided.

Growing community of inventors

Cambridge, United Kingdom

Mateusz Wydro